LPL Financial
STLN

LPL Financial’s Starling Oncology STLN Stock Holding History

LPL Financial’s Portfolio STLN Stock Details STLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$135K Sell
24,892
-36,173
-59% -$152K ﹤0.01% 5859
2026
Q1 		$187K Sell
61,065
-209,820
-77% -$643K ﹤0.01% 5524
2025
Q4 		$964K Buy
270,885
+3,900
+1% +$14.5K ﹤0.01% 4108
2025
Q3 		$932K Buy
+266,985
New +$915K ﹤0.01% 4063

Other funds holding STLN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JAIC
Josh Arnold Investment Consultant Edina, Minnesota $159M AUM 142.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

LPL Financial's STLN Position: Q2 2026 in Review

LPL Financial reduced its Starling Oncology (STLN) stake by 59% in Q2 2026, selling an estimated $152K and leaving 24,892 shares worth $135K. The position accounts for ﹤0.01% of the portfolio, ranked #5859.

LPL Financial first reported a position in STLN in Q3 2025 and has held it in 4 quarters since. The position peaked at $964K in Q4 2025. 119 funds tracked by Wall St. Rank hold STLN as of Q2 2026.

  • LPL Financial held 24,892 shares of Starling Oncology worth $135K as of Q2 2026.
  • LPL Financial sold 36,173 Starling Oncology shares in Q2 2026, an estimated $152K.
  • Starling Oncology made up ﹤0.01% of LPL Financial's portfolio in Q2 2026, its #5859 holding.
  • LPL Financial first reported a position in Starling Oncology in Q3 2025 and has held it in 4 quarters since.
  • LPL Financial's Starling Oncology position peaked at $964K in Q4 2025.
  • 119 funds tracked by Wall St. Rank held Starling Oncology as of Q2 2026.

Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.